UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~December 87, 2012

WINNER MEDICAL GROUP INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada		001-34484		33-0215298
(State or other jurisdiction of Incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

Winner Industrial Park, Bulong Road

Longhua, Shenzhen City, 518109

The People’s Republic of China

(Address of principal executive offices, including zip code)

(86) 755 2813-8888

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) x¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1Item 5.07. Submission of Matters to a Vote of Stock Holders.

~~Item~~On 8December 7, 2012, Winner Medical Group, Inc.01 ~~Other~~(the ~~Events~~“Company”) held a special meeting (the “Special Meeting”) of its stockholders. The Company’s independent inspector of elections reported the vote of the stockholders as follows:

On1. Proposal ~~November~~1: 8To approve the Agreement and Plan of Merger, ~~2012~~dated as of July 24, ~~Winner~~2012 ~~Medical~~(the ~~Group~~“Merger ~~Inc.~~Agreement”), ~~issued~~by aand ~~press~~among the Company, Winner ~~release.~~Holding ALimited, ~~copy~~a ofCayman ~~that~~Islands ~~press~~exempted ~~release~~company iswith ~~attached~~limited ~~hereto~~liability as(“Parent”) ~~Exhibit~~and 99Winner Acquisition, Inc.1, a Nevada corporation and isa ~~incorporated~~wholly-owned, ~~herein~~direct bysubsidiary ~~reference~~of Parent.

Item 9.01 Financial Statements and Exhibits.

Votes For		Votes Against		Abstentions		Broker Non-Votes
22,059,264		84,607		7,525		0

Exhibit No.		Description
99.1		Press Release of Winner Medical Group Inc., dated November 8, 2012

As Proposal 1 was passed, a second proposal to adjourn the meeting, if necessary, was not considered by the stockholders at the meeting.

2Item 8.01. Other Events

~~SIGNATURES~~On December 7, 2012, the Company issued a press release relating to the announcement of the results of the Special Meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

~~Pursuant~~Item to9.01. ~~the~~Financial ~~requirements~~Statements ofand ~~the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~Exhibits

	Winner Medical Group Inc.
Date: November 8, 2012	By:	/s/ Jianquan Li
		Jianquan Li
		President and Chief Executive Officer

3. (d) Exhibits

Exhibit Number		Description
99.1		Press release, dated December 7, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Winner Medical Group Inc.

		By:	/s/ Xiuyuan Fang
			Xiuyuan Fang
			Chief Financial Officer and Treasurer

Date: December 7, 2012

Filing Compare · WINNER MEDICAL GROUP INC